Hybrid Silica Technologies

Vedanta Biosciences, Inc., based in Cambridge, MA, is at the forefront of developing first-in-class Live Biotherapeutic Products (LBPs) to address serious gastrointestinal diseases through the strategic use of defined bacterial consortia. The company is focused on advancing innovative treatments for conditions such as inflammatory bowel disease and recurrent Clostridium difficile infections, with ongoing clinical trials to evaluate the efficacy and safety of its drug candidates. Committed to improving patient outcomes, Vedanta emphasizes the importance of gut health and the role of dysbiosis in gastrointestinal disorders. Through a robust scientific framework, the company leverages its expertise in immune response stimulation and microbial therapies to usher in a new era of gastrointestinal health management. Generated from the website

Kebotix Inc, based in Cambridge, MA, specializes in transforming materials innovation through its advanced AI platform, which accelerates the discovery of chemicals and materials. By leveraging a self-driving lab that integrates cloud technologies, machine learning, and automation, Kebotix aims to bring better products to market faster and enhance the research and development process for its partners. Generated from the website